Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.14 Billion CNY | 22.32% |
| 2022 | 936.41 Million CNY | 28.78% |
| 2021 | 727.12 Million CNY | 26.6% |
| 2020 | 574.33 Million CNY | 52.9% |
| 2019 | 375.61 Million CNY | 26.91% |
| 2018 | 295.96 Million CNY | 20.24% |
| 2017 | 246.14 Million CNY | 35.03% |
| 2016 | 182.29 Million CNY | 52.19% |
| 2015 | 119.77 Million CNY | 31.53% |
| 2014 | 91.06 Million CNY | 16.99% |
| 2013 | 77.83 Million CNY | 40.08% |
| 2012 | 55.56 Million CNY | 31.79% |
| 2011 | 42.16 Million CNY | 10.73% |
| 2010 | 38.07 Million CNY | 4.49% |
| 2009 | 36.44 Million CNY | 14.35% |
| 2008 | 31.87 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion CNY | 3.14% |
| 2024 Q3 | 1.14 Billion CNY | -6.6% |
| 2024 Q1 | 1.18 Billion CNY | 3.83% |
| 2023 Q3 | 1.12 Billion CNY | 3.6% |
| 2023 FY | 1.14 Billion CNY | 22.32% |
| 2023 Q2 | 1.08 Billion CNY | 3.21% |
| 2023 Q4 | 1.14 Billion CNY | 2.11% |
| 2023 Q1 | 1.04 Billion CNY | 12.03% |
| 2022 Q3 | 744.21 Million CNY | -2.72% |
| 2022 Q2 | 765.01 Million CNY | 9.06% |
| 2022 Q1 | 701.49 Million CNY | -3.53% |
| 2022 FY | 936.41 Million CNY | 28.78% |
| 2022 Q4 | 936.41 Million CNY | 25.83% |
| 2021 Q1 | 542.64 Million CNY | -5.52% |
| 2021 FY | 727.12 Million CNY | 26.6% |
| 2021 Q4 | 727.12 Million CNY | 6.93% |
| 2021 Q3 | 679.98 Million CNY | 8.98% |
| 2021 Q2 | 623.97 Million CNY | 14.99% |
| 2020 Q1 | 426.69 Million CNY | 13.6% |
| 2020 Q3 | 532.78 Million CNY | 18.74% |
| 2020 Q4 | 574.33 Million CNY | 7.8% |
| 2020 FY | 574.33 Million CNY | 52.9% |
| 2020 Q2 | 448.69 Million CNY | 5.16% |
| 2019 Q1 | 337.91 Million CNY | 14.17% |
| 2019 FY | 375.61 Million CNY | 26.91% |
| 2019 Q4 | 375.61 Million CNY | -23.29% |
| 2019 Q3 | 489.64 Million CNY | 38.37% |
| 2019 Q2 | 353.87 Million CNY | 4.72% |
| 2018 Q3 | 290.13 Million CNY | 5.29% |
| 2018 Q4 | 295.96 Million CNY | 2.01% |
| 2018 Q2 | 275.56 Million CNY | -2.32% |
| 2018 FY | 295.96 Million CNY | 20.24% |
| 2018 Q1 | 282.11 Million CNY | 14.61% |
| 2017 Q4 | 246.14 Million CNY | 41.06% |
| 2017 Q3 | 174.49 Million CNY | -0.42% |
| 2017 Q2 | 175.22 Million CNY | 12.17% |
| 2017 Q1 | 156.21 Million CNY | -14.31% |
| 2017 FY | 246.14 Million CNY | 35.03% |
| 2016 Q1 | 141.01 Million CNY | 17.73% |
| 2016 FY | 182.29 Million CNY | 52.19% |
| 2016 Q4 | 182.29 Million CNY | -7.03% |
| 2016 Q3 | 196.06 Million CNY | 24.41% |
| 2016 Q2 | 157.59 Million CNY | 11.75% |
| 2015 Q3 | 119.22 Million CNY | 20.35% |
| 2015 Q2 | 99.06 Million CNY | 9.35% |
| 2015 Q1 | 90.59 Million CNY | -0.52% |
| 2015 FY | 119.77 Million CNY | 31.53% |
| 2015 Q4 | 119.77 Million CNY | 0.47% |
| 2014 Q1 | 75.51 Million CNY | -2.98% |
| 2014 Q2 | 78.19 Million CNY | 3.55% |
| 2014 FY | 91.06 Million CNY | 16.99% |
| 2014 Q4 | 91.06 Million CNY | 17.03% |
| 2014 Q3 | 77.81 Million CNY | -0.49% |
| 2013 Q4 | 77.83 Million CNY | -11.38% |
| 2013 FY | 77.83 Million CNY | 40.08% |
| 2013 Q3 | 87.83 Million CNY | 16.97% |
| 2013 Q2 | 75.09 Million CNY | 19.23% |
| 2013 Q1 | 62.97 Million CNY | 13.33% |
| 2012 Q1 | 44.8 Million CNY | 6.27% |
| 2012 Q3 | 65.49 Million CNY | 29.76% |
| 2012 Q4 | 55.56 Million CNY | -15.15% |
| 2012 FY | 55.56 Million CNY | 31.79% |
| 2012 Q2 | 50.47 Million CNY | 12.64% |
| 2011 Q3 | 41.97 Million CNY | -3.2% |
| 2011 Q2 | 43.36 Million CNY | 0.0% |
| 2011 FY | 42.16 Million CNY | 10.73% |
| 2011 Q4 | 42.16 Million CNY | 0.45% |
| 2010 FY | 38.07 Million CNY | 4.49% |
| 2010 Q4 | 38.07 Million CNY | 0.0% |
| 2009 FY | 36.44 Million CNY | 14.35% |
| 2008 FY | 31.87 Million CNY | 0.0% |